Visagar Polytex Ltd

Visagar Polytex Ltd experienced a challenging week, with its stock price declining by 5.17% from ₹0.58 to ₹0.55, underperforming the Sensex which fell by 0.78% over the same period. The week was marked by a significant downgrade in the company’s quality and rating, reflecting deteriorating fundamentals and bearish technical signals that weighed heavily on investor sentiment.

The next results date for Visagar Polytex Ltd is 29 May 2026.

The next results date for Visagar Polytex Ltd is 09 February 2026.

As of December 4, 2025, Visagar Polytex is considered very expensive and overvalued, with a negative PE ratio of -1.33, an EV to EBITDA ratio of -26.74, and a troubling ROE of -1560.00%, significantly underperforming compared to peers like K P R Mill Ltd and Trident, and showing a year-to-date return of -31.73% against the Sensex's 9.12%.

On 21-Nov, Visagar Polytex Ltd witnessed a notable decline in its share price, falling by 5.19% to close at ₹0.73. This drop reflects a continuation of the stock’s recent underperformance relative to both its sector and broader market benchmarks.

Visagar Polytex has experienced a significant decline in financial performance from Mar'19 to Mar'25, with net sales dropping to 0.00 Cr, negative operating profit, and total assets decreasing from 33.77 Cr to 7.03 Cr, indicating severe operational and financial challenges.

Visagar Polytex has experienced significant financial decline, with net sales dropping to 0.00 Cr in Mar'25 from 8.21 Cr in Mar'24, resulting in negative operating profit margins and increasing losses. Total assets and liabilities both decreased to 7.03 Cr in Mar'25, reflecting a challenging financial environment.

As of 12-Nov, Visagar Polytex Ltd's stock price is at 0.80, up 3.9% recently, but it has a year-to-date decline of 23.08%. Despite short-term gains, the stock faces challenges in regaining investor confidence due to significant longer-term losses.

The next results date for Visagar Polytex is 11 November 2025.

As of 10-Nov, Visagar Polytex Ltd's stock price is at 0.76, down 2.56%, and has underperformed its sector and the benchmark Sensex significantly over various time frames. The stock is in a bearish trend, trading below all key moving averages, with a year-to-date decline of 26.92%.

As of 24-Oct, Visagar Polytex Ltd's stock price is 0.81, having increased by 1.25% recently. Despite a short-term gain of 8.00% over the past week, the stock has a year-to-date decline of 22.12%, indicating ongoing long-term challenges.

As of October 23, 2025, Visagar Polytex is considered overvalued and risky due to troubling financial ratios, significant underperformance against the Sensex, and a shift in valuation grade from very attractive to risky.

Visagar Polytex has experienced a significant decline in financial performance, with net sales dropping from 53.83 crore in March 2019 to 0.00 crore by March 2025, resulting in negative operating profit and a complete halt in cash generation from operations. Total assets also decreased sharply, reflecting the company's deteriorating financial health.

As of October 17, 2025, Visagar Polytex is considered very attractive and undervalued compared to peers, despite a challenging financial position indicated by a negative PE ratio and lagging stock performance, suggesting potential for recovery.

As of October 17, 2025, Visagar Polytex is considered very attractive and undervalued despite its negative PE ratio of -1.41 and operational challenges, especially when compared to peers like K P R Mill Ltd and Trident, highlighting potential upside if the company stabilizes its operations.

As of October 17, 2025, Visagar Polytex is considered undervalued and very attractive for investment, despite recent negative returns, due to its significantly low valuation ratios compared to peers like K P R Mill Ltd and Trident.

Visagar Polytex has experienced a significant decline in net sales and profitability, with net sales dropping from 53.83 Cr in March 2019 to 0.00 Cr by March 2025, leading to a complete halt in operations. The company's financial health deteriorated, resulting in increasing losses and a substantial reduction in total assets and liabilities.